"Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation

European Respiratory Review

Volumn 20, Issue 122, 2011, Pages 297-300

  Hoeper, M M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; ILOPROST; SILDENAFIL;

ADULT; CARDIOPULMONARY EXERCISE TEST; CARDIOPULMONARY HEMODYNAMICS; CASE REPORT; DRUG DOSE INCREASE; DRUG TOLERABILITY; EXTRACORPOREAL OXYGENATION; FEMALE; FUNCTIONAL STATUS; GENERAL CONDITION DETERIORATION; HEART CATHETERIZATION; HEART FAILURE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; HYPERTRANSAMINASEMIA; IDIOPATHIC DISEASE; KIDNEY FAILURE; LACTIC ACIDOSIS; LETTER; LUNG TRANSPLANTATION; MONOTHERAPY; PATIENT MONITORING; PULMONARY HYPERTENSION;

ADULT; ANTIHYPERTENSIVE AGENTS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; LUNG TRANSPLANTATION; PIPERAZINES; PURINES; SULFONAMIDES; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 82555191284     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/09059180.00005511     Document Type: Letter

References (28)

1. Galié N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-1263.
2. Clinical Trials.gov. A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension (PAH) (AMBITION). NCT01178073. www.clinicaltrials.gov Date last updated: May 26, 2011. Date last accessed: June 16, 2011.
3. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322-329.
4. Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-788.
5. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002; 106: 1477-1482.
6. Vachiéry JL. Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy. Adv Ther 2011; 28: 251-269.
7. Delcroix M, Spaas K, Quarck R. Long-term outcome in pulmonary arterial hypertension: a plea for earlier parenteral prostacyclin therapy. Eur Respir Rev 2009; 18: 253-259.
8. Goldsmith DR, Wagstaff AJ. Inhaled iloprost: in primary pulmonary hypertension. Drugs 2004; 64: 763-773.
9. Hoeper MM, Spiekerkoetter E, Westerkamp V, et al. Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension. Eur Respir J 2002; 20: 339-343.
10. Higenbottam T, Butt AY, McMahon A, et al. Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension. Heart 1998; 80: 151-155.
11. Higenbottam TW, Butt AY, Dinh-Xaun AT, et al. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart 1998; 79: 175-179.
12. Hoeper MM, Gall H, Seyfarth HJ, et al. Long-term outcome with intravenous iloprost in pulmonary arterial hypertension. Eur Respir J 2009; 34: 132-137.
13. Jackson A, Cropper J, Pye R, et al. Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant 2008; 27: 348-352.
14. Marasco SF, Lukas G, McDonald M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ 2008; 17: Suppl. 4, S41-S47.
15. Iacono A, Groves S, Garcia J, et al. Lung transplantation following 107 days of extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 2010; 37: 969-971.
16. Aigner C, Wisser W, Taghavi S, et al. Institutional experience with extracorporeal membrane oxygenation in lung transplantation. Eur J Cardiothorac Surg 2007; 31: 468-474.
17. Pereszlenyi A, Lang G, Steltzer H, et al. Bilateral lung transplantation with intra-and postoperatively prolonged ECMO support in patients with pulmonary hypertension. Eur J Cardiothorac Surg 2002; 21: 858-863.
18. Gregoric ID, Chandra D, Myers TJ, et al. Extracorporeal membrane oxygenation as a bridge to emergency heart-lung transplantationin a patient with idiopathic pulmonary arterial hypertension. J Heart Lung Transplant 2008; 27: 466-468.
19. Olsson KM, Simon A, Strueber M, et al.; Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant 2010; 10: 2173-2178.
20. Wiklund L, Haraldsson A, Selimovic N, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation in a patient with persistent severe porto-pulmonary arterial hypertension following liver transplantation. Eur J Cardiothorac Surg 2011; 39: 777-778.
21. Hämmäinen P, Schersten H, Lemström K, et al. Usefulness of extracorporeal membrane oxygenation as a bridge to lung transplantation: a descriptive study. J Heart Lung Transplant 2011; 30: 103-107.
22. Strueber M. Extracorporeal support as a bridge to lung transplantation. Curr Opin Crit Care 2010; 16: 69-71.
23. Walles T. Clinical experience with the iLA Membrane Ventilator pumpless extracorporeal lung-assist device. Expert Rev Med Devices 2007; 4: 297-305.
24. de Perrot M, Granton JT, McRae K, et al. Impact of extracorporeal life support on outcome in patients with idiopathic pulmonary arterial hypertension awaiting lung transplantation. J Heart Lung Transplant 2011; 30: 997-1002.
25. Strueber M, Hoeper MM, Fischer S, et al. Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. AmJ Transplant 2009; 9: 853-857.
26. Fischer S, Hoeper MM, Tomaszek S, et al. Bridge to lung transplantation with the extracorporeal membrane ventilator Novalung in the veno-venous mode: the initial Hannover experience. ASAIO J 2007; 53: 168-170.
27. Fischer S, Simon AR, Welte T, et al. Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg 2006; 131: 719-723.
28. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-163.